103 related articles for article (PubMed ID: 2824044)
1. The EGF receptor: structure, regulation and potential role in malignancy.
Thompson DM; Gill GN
Cancer Surv; 1985; 4(4):767-88. PubMed ID: 2824044
[TBL] [Abstract][Full Text] [Related]
2. The erbB gene and the EGF receptor.
Martin GS
Cancer Surv; 1986; 5(2):199-219. PubMed ID: 2877733
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the epidermal growth factor receptor by phosphorylation.
Bertics PJ; Weber W; Cochet C; Gill GN
J Cell Biochem; 1985; 29(3):195-208. PubMed ID: 3001110
[TBL] [Abstract][Full Text] [Related]
4. The role of the neu oncogene product in cell transformation and normal development.
Kokai Y; Wada T; Myers JN; Brown VI; Dobashi K; Cohen J; Hamuro J; Weiner DB; Greene MI
Princess Takamatsu Symp; 1988; 19():45-57. PubMed ID: 2908355
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
Ram TG; Ethier SP
Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
[TBL] [Abstract][Full Text] [Related]
6. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor.
Chen WS; Lazar CS; Poenie M; Tsien RY; Gill GN; Rosenfeld MG
Nature; 1987 Aug 27-Sep 2; 328(6133):820-3. PubMed ID: 3498122
[TBL] [Abstract][Full Text] [Related]
7. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N
Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414
[TBL] [Abstract][Full Text] [Related]
8. Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor.
Chazin VR; Kaleko M; Miller AD; Slamon DJ
Oncogene; 1992 Sep; 7(9):1859-66. PubMed ID: 1354348
[TBL] [Abstract][Full Text] [Related]
9. Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.
Liu SM; Carpenter G
J Cell Physiol; 1993 Nov; 157(2):237-42. PubMed ID: 7901224
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2.
Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP
Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535
[TBL] [Abstract][Full Text] [Related]
11. Effects of epidermal growth factor on transferrin receptor phosphorylation and surface expression in malignant epithelial cells.
Castagnola J; MacLeod C; Sunada H; Mendelsohn J; Taetle R
J Cell Physiol; 1987 Sep; 132(3):492-500. PubMed ID: 3498729
[TBL] [Abstract][Full Text] [Related]
12. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
Comoglio PM
EXS; 1993; 65():131-65. PubMed ID: 8380735
[TBL] [Abstract][Full Text] [Related]
13. Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors.
Haley JD; Hsuan JJ; Waterfield MD
Oncogene; 1989 Mar; 4(3):273-83. PubMed ID: 2784850
[TBL] [Abstract][Full Text] [Related]
14. Ligand-independent oncogenic transformation by the EGF receptor requires kinase domain catalytic activity.
Danielsen AJ; Maihle NJ
Exp Cell Res; 2002 Apr; 275(1):9-16. PubMed ID: 11925101
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
Faaland CA; Laskin JD; Thomas TJ
Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
[TBL] [Abstract][Full Text] [Related]
16. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
17. The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.
Suárez Pestana E; Tenev T; Gross S; Stoyanov B; Ogata M; Böhmer FD
Oncogene; 1999 Jul; 18(28):4069-79. PubMed ID: 10435588
[TBL] [Abstract][Full Text] [Related]
18. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
Gardner DP; Shimizu N
J Cell Physiol; 1994 Feb; 158(2):245-55. PubMed ID: 8106561
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
20. The fms gene and the CSF-1 receptor.
Sherr CJ; Rettenmier CW
Cancer Surv; 1986; 5(2):221-32. PubMed ID: 3022923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
